Mouse-human chimeric anti-CXADR antibody shows antitumor activity in prostate and SCLC models Nov. 14, 2019
First-in-class fusion inhibitor against diverse and multidrug-resistant HCV strains presented Nov. 14, 2019
New exploratory phase I/II study in Japan assesses NS-089 in Duchenne muscular dystrophy Nov. 13, 2019
RSS